fentanyl

Poland

Drugs containing this active substance

  • DUROGESIC

    The medicine is intended for the treatment of severe chronic pain in adults requiring continuous administration of analgesics, and in children over 2 years of age who have already used opioid medicines and require continuous administration of analgesics.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 4.2 mg/10.5 cm2

    ATC: N02AB03

    Manufacturer: Janssen Pharmaceutica N.V.

  • DUROGESIC

    The medicine is intended for the treatment of severe chronic pain in adults and in children over 2 years of age who are already using opioid medicines and require continuous analgesic administration.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 8.4 mg/21 cm2

    ATC: N02AB03

    Manufacturer: Janssen Pharmaceutica N.V.

  • DUROGESIC

    The medicine is intended for the treatment of severe chronic pain in adults requiring continuous administration of analgesics, and in children over 2 years of age who have already used opioid medicines and require continuous administration of analgesics.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 12.6 mg/31.5 cm2

    ATC: N02AB03

    Manufacturer: Janssen Pharmaceutica N.V.

  • DUROGESIC

    It is used in the treatment of severe chronic pain in adults and in children over 2 years of age who have previously used opioid medications and require continuous administration of analgesics.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 16.8 mg/42 cm2

    ATC: N02AB03

    Manufacturer: Janssen Pharmaceutica N.V.

  • DUROGESIC

    The medicinal product is intended for the treatment of severe chronic pain in adults requiring continuous analgesic therapy, and in children over 2 years of age who have already been using opioid medicines and require continuous analgesic therapy.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 2.1 mg/5.25 cm2

    ATC: N02AB03

    Manufacturer: Janssen Pharmaceutica N.V.

  • FENTA MX 100

    The medicine helps to relieve very severe, chronic pain in adults and children over 2 years of age who have previously received opioid medicines and require continuous analgesic treatment.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 23.12 mg

    ATC: N02AB03

    Manufacturer: Hexal AG

  • FENTA MX 25

    This medicine helps to relieve very severe, chronic pain in adults and in children over 2 years of age who have previously received opioid medicines.

    Form: plaster, transdermal system

    Active substance Dosage
    fentanyl 5.78 mg

    ATC: N02AB03

    Manufacturer: Hexal AG

  • FENTA MX 50

    Fenta MX patches help relieve very severe, chronic pain in adults and children over 2 years of age who are already receiving opioid medicines and require continuous pain relief.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 11.56 mg

    ATC: N02AB03

    Manufacturer: Hexal AG

  • FENTA MX 75

    The medicine helps to relieve very severe, chronic pain in adults and children over 2 years of age who have previously received opioid medicines and require continuous analgesic treatment.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 17.34 mg

    ATC: N02AB03

    Manufacturer: Hexal AG

  • FENTANYL ACTAVIS

    The medicine is intended for the treatment of severe chronic pain in adults and in children over 2 years of age who have previously used opioid medicines.

    Form: plaster, transdermal system

    Active substance Dosage
    fentanyl 4.125 mg

    ATC: N02AB03

    Manufacturer: Actavis Group PTC ehf., Luye Pharma AG, Merckle GmbH

  • FENTANYL ACTAVIS

    The medicine is intended for the treatment of severe chronic pain in adults and children over 2 years of age who have previously used opioid medicines.

    Form: plaster, transdermal system

    Active substance Dosage
    fentanyl 75 mcg/h

    ATC: N02AB03

    Manufacturer: Actavis Group PTC ehf., Luye Pharma AG, Merckle GmbH

  • FENTANYL ACTAVIS

    The medicine is intended for the treatment of severe chronic pain in adults and children over 2 years of age who have previously used opioid medicines and require continuous analgesic administration.

    Form: plaster, transdermal system

    Active substance Dosage
    fentanyl 16.5 mg

    ATC: N02AB03

    Manufacturer: Actavis Group PTC ehf., Luye Pharma AG, Merckle GmbH

  • FENTANYL ACTAVIS

    The medicine is intended for the treatment of severe chronic pain in adults and children over 2 years of age who are already using opioid medicines and require continuous analgesic administration.

    Form: plaster, transdermal system

    Active substance Dosage
    fentanyl 8.25 mg

    ATC: N02AB03

    Manufacturer: Actavis Group PTC ehf., Luye Pharma AG, Merckle GmbH

  • FENTANYL KALCEKS

    It is a potent analgesic from the opioid group. It is used as an adjunct to general or regional anesthesia, for induction of anesthesia, for maintenance of anesthesia, and as an anesthetic with oxygen in high-risk patients during surgery.

    Form: solution for injection

    Active substance Dosage
    fentanyl 0.05 mg/ml

    ATC: N01AH01

    Manufacturer: AS Kalceks

  • MATRIFEN 100 MICROGRAMS/HOUR TRANSDERMAL SYSTEM

    The medicine is intended for the treatment of chronic pain in adults and children over 2 years of age who have previously used opioid medications and require continuous analgesic administration.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 11 mg

    ATC: N02AB03

    Manufacturer: LTS Lohmann Therapy Systems Inc.

  • MATRIFEN 12 MICROGRAMS/HOUR TRANSDERMAL SYSTEM

    Matrifen is intended for the treatment of chronic pain in adults and children over 2 years of age who are already using opioid medications and require continuous analgesic administration.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 1.38 mg

    ATC: N02AB03

    Manufacturer: LTS Lohmann Therapie-Systeme GmbH

  • MATRIFEN 25 MICROGRAMS/HOUR TRANSDERMAL SYSTEM

    The medicine is intended for the treatment of chronic pain in adults and children over 2 years of age who have previously used opioid medicines and require continuous administration of analgesics.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 2.75 mg

    ATC: N02AB03

    Manufacturer: LTS Lohmann Therapie-Systeme GmbH

  • MATRIFEN 50 MICROGRAMS/HOUR TRANSDERMAL SYSTEM

    Matrifen is intended for the treatment of chronic pain in adults and children over 2 years of age who have previously used opioid medications and require continuous analgesic administration.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 5.5 mg

    ATC: N02AB03

    Manufacturer: LTS Lohmann Therapy Systems Inc.

  • MATRIFEN 75 MICROGRAMS/HOUR TRANSDERMAL SYSTEM

    The medicine is intended for the treatment of chronic pain in adults and children over 2 years of age who are already using opioid medications and require continuous analgesic administration.

    Form: system, transdermal

    Active substance Dosage
    fentanyl 8.25 mg/25.2 cm2

    ATC: N02AB03

    Manufacturer: LTS Lohmann Therapy Systems Inc.